Med-X, Inc. and Pacific Shore Holdings, Inc. have entered into a definitive merger and acquisition agreement. Via the agreement, Med-X, an ancillary cannabis company and a leader in cannabis media and cultivation services arena, will combine with PSH, a global green pest control company and over-the-counter pharmacy products supplier. This business combination will create a leader in the development of commercial and consumer products, integrated pest management services and pain management solutions. The merger is expected to close during the first quarter of 2018. Under the terms of the Agreement, PSH shareholders will tender two shares of common stock, in exchange for one share of Med-X common stock. The terms have been unanimously approved by both companies' boards of directors.


Upon the closing of the merger, the following divisions will be recognized under the combined companies, Med-X, Inc.'s portfolio:

Nature-Cide - Natural Insecticides / Pesticides developed and deployed in commercial pest control, janitorial, hospitality and agriculture including cannabis cultivation. Distributed globally by Target Specialty Products and Rentokil.

Nature-Cide Cultivation - Large scale, regulated cannabis cultivation and cultivation services and solutions in California.

Thermal-Aid - Natural heating and cooling modalities for pain management for the entire family. Distributed domestically by Cardinal Health and Independence Medical.

The Marijuana Times - Global digital media news network.

Maliblu Brands - Organic Cannabis & Hemp derived products developed for a variety of medical conditions, including but not limited to pain Management, PTSD and sleep disorders.

Home Spa Products - Aromatherapy spa products for personal use.



According to the companies, Med-X is in the midst of a resurgence as a thought leader in the cannabis space, especially in regard to exposing certain blemished areas of the industry such as the widespread unregulated pesticide use by cultivators, and the dangerous health impacts of consuming products with high levels of synthetic chemicals. In continuing to expand industry awareness, the company announced in December of 2017, that it plans to scale up and continue expanding its media network division, The Marijuana Times to help promote industry leaders who deserve to be recognized for their hard work, and healthy contributions to the transforming legal cannabis industry. PSH has transformed from a diversified holding company to a streamlined operating company with a focused and leading green products portfolio in pest control, pain management and healthy living manufacturing. PSH combines its best-in-class products with its first-class reputation and customer support. The company's core strengths include essential oil blending and manufacturing, advanced integrated pest management, pain management solutions as well as world-class branding and marketing.


To facilitate this transaction, Med-X majority shareholder, President and COO Matthew Mills will surrender approximately 79% of his Med-X common stock ownership. This combined with the 10% outstanding Med-X shares owned by PSH will facilitate the exchange. Once this transaction is complete with all of the PSH shareholders, Med-X shareholders will not experience any dilution with their current holdings. Upon closing of the merger, Mills will then hold approximately 14% of the outstanding common stock of the combined company. Mills will remain in control of the combined company with the issuance of preferred stock which will have only voting share rights. This will allow senior management and the board of directors to maintain control of the company after the merger.


"The proposed combination of Med-X and PSH represents the next stage of our continued growth to become a global leader in green medicine technologies," stated Dr. David E. Toomey, chief executive officer, Med-X, Inc. "With its international and domestic distribution partnerships in place, PSH aligns with and enhances the Med-X cannabis platform and further positions all of our business divisions for global growth. Through this transaction, we will also expand our ability to further invest in or acquire other companies in the space, develop new innovative solutions for customers and increase shareholder value," stated Toomey.


"We expect this transaction, combined with our growth plans for 2018 and beyond, to propel the combined company forward.  It should also fuel our continued efforts with our Regulation A+ Crowdfunding initiative, which allows everyday Americans to participate with an investment of $420 for 700 shares in the company. This transaction should offer greater value to our shareholders, customers and employees as well open some doors within the investment banking community," explained Med-X, Inc. President and Chief Operating Officer Matthew Mills.


Under the terms of the proposed transaction, the businesses of Med-X and PSH will be combined under Med-X which will retain the name, "Med-X, Inc." Upon the closing of the transaction, the combined company is expected to maintain Med-X's legal domicile and headquarters in Canoga Park, CA. According to Med-X, the combined company brings together product, technology and service capabilities across media, pest control, pain management, aromatherapy and essential oil manufacturing. As a leader in green medicine technologies, ultimately the combined company strives to help its customers achieve a higher quality of life with safe and responsible tools to do so. Sales will be conducted by various means including, international commercial distribution, OTC pharmacy retailers, ecommerce, and third-party service providers. The combination of Med-X and PSH creates immediate opportunities for near-term growth through enhancing the existing product lines and services to the growing legal cannabis market and cross-selling them through an established media network, in hopes to expand the global reach for the already established brands.


The newly merged company will also benefit by combining trade secrets and essential oil blending techniques for new products, advanced service solutions already proven effective in other industries, and value-added assets like patents, trademarks, intellectual properties and connectivity with mainstream distributors like Cardinal Health, Independence Medical, Target Specialty Products and Rentokil. As a result, the new company will be able to better partner with its customers inside the legal cannabis market to help improve their overall performance and operations, enhancing the experience for their own customers in areas such as health and wellness, potentially helping patients experience a better quality of life. In addition, the combined company will position a large licensed pest control network, of trained professionals ready to serve the expanding regulated global cannabis cultivation market.


Med-X is in the midst of a resurgence as a thought leader in the cannabis space, especially in regard to exposing certain blemished areas of the industry such as the widespread unregulated pesticide use by cultivators, and the dangerous health impacts of consuming products with high levels of synthetic chemicals. In continuing to expand industry awareness, the company announced in December of 2017, that it plans to scale up and continue expanding its media network division, The Marijuana Times to help promote industry leaders who deserve to be recognized for their hard work, and healthy contributions to the transforming legal cannabis industry.


PSH has transformed from a diversified holding company to a streamlined operating company with a focused and leading green products portfolio in pest control, pain management and healthy living manufacturing. PSH combines its best-in-class products with its first-class reputation and customer support. The company's core strengths include essential oil blending and manufacturing, advanced integrated pest management, pain management solutions as well as world-class branding and marketing.